The Holomovement Wave to Activate Asheville with Four Days of Unity, Inspiration and Collective Action — May 23–26, 2025
ASHEVILLE, N.C.–(BUSINESS WIRE)–#holomovement—The Holomovement, a global movement for unity and societal transformation, announces its flagship... Read more.
KBRA Assigns Preliminary Ratings to OBX 2025-NQM8 Trust
NEW YORK–(BUSINESS WIRE)–#creditratingagency–KBRA assigns preliminary ratings to six classes of mortgage-backed notes from OBX 2025-NQM8 Trust,... Read more.
INSERTING and REPLACING NeuReality Redefines AI Economics, Delivers Instant Access to LLMs Out of the Box While Lowering Total Cost of AI Inference
The NR1® AI Inference Appliance, powered by the first true AI-CPU, now comes pre-optimized with Llama, Mistral, Qwen, Granite, and other generative and agentic... Read more.
Westinghouse and INSA Lyon Collaborate to Accelerate Materials Innovation
WARSAW, Poland–(BUSINESS WIRE)–Westinghouse Electric Company and the Institut National des Sciences Appliquées (INSA) Lyon announced the signing of... Read more.
IPS HEART Granted Orphan Drug Designation in the EU for Becker Muscular Dystrophy
HOUSTON–(BUSINESS WIRE)–IPS HEART has been awarded Orphan Drug Designation (ODD) in the EU by the EUROPEAN MEDICINES AGENCY for GIVI-MPCs unique ability... Read more.
2 Day Pre-Filled Syringes End-to-End Processing Training Course: Extensive Coverage of Improvements in the Manufacturing Process (ONLINE EVENT: July 21-22, 2025) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Pre-Filled Syringes: End-to-End Processing Training Course” training has been added to ResearchAndMarkets.com’s... Read more.
Latus Bio Unveils AAV-Ep+ Capsid Variant Capable of Unprecedented Protein Production in the Brain
PHILADELPHIA–(BUSINESS WIRE)–#BattensDisease—Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in AAV gene therapy, has announced... Read more.
Cuick Trac Enclave Powers Beryllium InfoSec to CMMC Level 2 Certification
DALLAS–(BUSINESS WIRE)–Beryllium InfoSec, Inc., a cybersecurity and compliance firm serving the Defense Industrial Base (DIB), has officially achieved... Read more.
Dyno Therapeutics Announces Inaugural 2025 Genetic Agency Technology Conference and Launch of Dyno Frontiers Program to Accelerate Progress in Patient-Empowering Gene Therapies
The inaugural Genetic Agency Technology Conference (GATC) on November 11th, 2025 will convene technical thought leaders, gene therapy developers, patients, their... Read more.
Dyno Therapeutics Launches Three Breakthrough Capsid Delivery Vectors for Next-Generation Eye, Muscle and CNS Gene Therapies at the 2025 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Dyno’s AI-designed capsids improved therapeutic gene delivery to eye, muscle and CNS compared to commonly used AAV capsids, showcasing improved delivery efficiency,... Read more.